Abstract
Purpose. The assessment of the effects of nasal absorption enhancers on the rat nasal epithelium and membrane permeability in vivo after a single nasal dose of the enhancers.
Methods. The release of marker compounds (protein, cholesterol and acid phosphatase) from the nasal epithelium was measured using a lavage technique. The nasal membrane permeability was determined after intravenous administration of a systemic tracer (FITC-albumin).
Results. The effects of the absorption enhancers could be classified into four categories. The first consisted of HPβCD (5%), DMβCD (2%) and RAMEB (2%) and was not different from the control (physiological saline). For the second category, DMβCD (5%), effects were significantly higher than for the control. The third category, SGC (1%), was more active than DMβCD (5%) but less active than the last group. The fourth, most membrane damaging, category consisted of STDHF (1%), laureth-9 (1%) and LPC (1%). Administration of these three enhancers also resulted in release of acid phosphatase, indicating that severe membrane damage occurred. The release of cholesterol from nasal epithelium was largely dependent on the cholesterol solubilisation of the absorption enhancers. The amount of cholesterol released by laureth-9 and LPC was the largest.
Conclusions. The results of this in vivo study are in agreement (i.e. similarity in rank order) with morphological and ciliotoxicity studies of nasal absorption enhancers, demonstrating that this in vivo model is a valuable tool to classify nasal absorption enhancers according to their effects on the rat nasal epithelium.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
REFERENCES
F.W.H.M. Merkus, N.G.M. Schipper, W.A.J.J. Hermens, S.G. Romeijn and J.C. Verhoef. Absorption enhancers in nasal drug delivery: efficacy and safety. J. Control. Rel. 24:201–208 (1993).
R.D. Ennis, L. Borden and W.A. Lee. The effects of permeation enhancers on the surface morphology of the rat nasal mucosa: A scanning electron microscopy study. Pharm. Res. 7:468–475 (1990).
S.G. Chandler, L. Illum, and N.W. Thomas. Nasal absorption in rats. II. Effect of enhancers on insulin absorption and nasal histology. Int. J. Pharm. 76:61–70 (1991).
I.J. Gill, A.N. Fisher, M. Hinchcliffe, J. Whetstone, N. Farraj, R. De Ponti and L. Illum. Cyclodextrins as protection agents against enhancer damage in nasal delivery systems II. Effect on in vivo absorption of insulin and histopathology of nasal membrane. Eur. J. Pharm. Sci. 1:237–248 (1994).
W.A.J.J. Hermens and F.W.H.M. Merkus. The influence of drugs on nasal ciliary movement. Pharm. Res. 4:445–449 (1987).
N.G.M. Schipper, J. Verhoef, S.G. Romeijn, and F.W.H.M. Merkus. Absorption enhancers in nasal insulin delivery and their influence on nasal ciliary functioning. J. Control. Rel. 21:173–186 (1992).
Z. Shao, R. Krishnamoorthy, and A.K. Mitra. Cyclodextrins as nasal absorption promoters of insulin: mechanistic evaluations. Pharm. Res. 9:1157–1163 (1992).
T. Irie, K. Wakamatsu, H. Arima, H. Aritomi and K. Uekama. Enhancing effects of cyclodextrins on nasal absorption of insulin in rats. Int. J. Pharm. 84:129–139 (1992).
Z. Shao, and A.K. Mitra. Nasal membrane and intracellular protein and enzyme release by bile salts and bile salt-fatty acid mixed micelles: correlation with facilitated drug transport. Pharm. Res. 9:1184–1189 (1992).
C.P. Pujara, Z. Shao, M.R. Duncan and A.K. Mitra. Effects of formulation variables on nasal epithelial cell integrity: biochemical evaluations. Int. J. Pharm. 114:197–203 (1995).
S. Hirai, T. Yashiki, T. Matsuzawa, and H. Mima. Absorption of drugs from the nasal mucosa of rat. Int. J. Pharm. 7:317–325 (1981).
S. Gizurarson. The relevance of nasal physiology to the design of drug absorption studies. Advan. Drug. Del. Rev. 11:329–347 (1993).
G. Petersson, and E. Svensjö. Nasal mucosal permeability after methacholine, substance P, and capsaicin challenge in rat. Int. J. Microcirc: Clin. Exp. 9:205–212 (1990).
O.H. Lowry, N.J. Rosebrough, A.L. Farr, and R.J. Randall. Protein measurement with Folin phenol reagent. J. Biol. Chem. 193:265–275 (1951).
K. Watanabe, I. Watanabe, Y. Saito and V. Mizuhira. Characteristics of capillary permeability in nasal mucosa. Ann. Otol. 89:377–382 (1980).
H.W. Randall, M.S. Bogdanffy, and K.T. Morgan. Enzyme histochemistry of the rat nasal mucosa embedded in cold glycol methacrylate. Am. J. Anat. 179:10–17 (1987).
K. Nakanishi, T. Nadai, M. Masada, and K. Miyajima. Effect of cyclodextrins on biological membranes. 2. Mechanism of enhancement on the intestinal absorption of non-absorbable drug by cyclodextrins. Chem. Pharm. Bull. 40:1252–1256 (1992).
F.W.H.M. Merkus, J. Verhoef, S.G. Romeijn and N.G.M. Schipper. Absorption enhancing effect of cyclodextrins on intranasally administered insulin in rats. Pharm. Res. 8:588–592 (1991).
M.D. Donovan, G.L. Flynn, and G.L. Amidon. The molecular weight dependence of nasal absorption: the effects of absorption enhancers. Pharm. Res. 7:808–815 (1990).
T. Kissel, J. Drewe, S. Bantle, A. Rummelt, C. Beglinger. Tolerability and absorption enhancement of intranasally administered octreotide by sodium taurodihydrofusidate in healthy subjects. Pharm. Res. 9:52–57 (1992).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Marttin, E., Verhoef, J.C., Romeijn, S.G. et al. Effects of Absorption Enhancers on Rat Nasal Epithelium in Vivo: Release of Marker Compounds in the Nasal Cavity. Pharm Res 12, 1151–1157 (1995). https://doi.org/10.1023/A:1016207809199
Issue Date:
DOI: https://doi.org/10.1023/A:1016207809199